Two previous studies found that loss-of-function variants in ANGPTL3 protected against CAD.3,47 In an effort to reproduce these findings, we performed a sensitivity MR analysis of CAD and limited the selection of genetic instruments to functional variants. The gene discussed is ANGPTL3; the disease is coronary artery disorder.